triphenyltetrazolium has been researched along with cilostazol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunningham, L; Hakaim, AG; Hoover, K; White, JL | 1 |
1 other study(ies) available for triphenyltetrazolium and cilostazol
Article | Year |
---|---|
Selective type III phosphodiesterase inhibition prevents elevated compartment pressure after ischemia/reperfusion injury.
Topics: Animals; Anterior Compartment Syndrome; Cilostazol; Hindlimb; Muscle, Skeletal; Oxygen Consumption; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Pressure; Rabbits; Reperfusion Injury; Tetrazoles; Tetrazolium Salts; Vasodilator Agents | 1999 |